SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patientsSARS-CoV-2 바이러스혈증은 COVID-19 환자의 급속한 악화를 예측할 수 있습니다Article Published on 2020-11-012022-09-11 Journal: The Brazilian journal of infectious diseases : an [Category] SARS, 치료기술, [키워드] accompanied addition asynchrony Blood blood oxygen clearance COVID-19 COVID-19 patient COVID-19 pneumonia decrease Deterioration heart rate Hypoxemia indicate inflammation storm Injury lead Lung CT marker multiple organ multiple organs nucleic acid nucleic acid test oxygen pandemic Pneumonia poor prognosis positive positive COVID-19 predict raised Rapid Replication report SARS-CoV-2 SARS-CoV-2 nucleic acid Septic shock tendency Viremia [DOI] 10.1016/j.bjid.2020.08.010 PMC 바로가기 [Article Type] Article
Information about COVID-19 among Selected Population of Eastern Nepal: A Descriptive Cross-sectional StudyOriginal Article Published on 2020-10-312022-10-30 Journal: JNMA: Journal of the Nepal Medical Association [Category] COVID-19, MERS, SARS, [키워드] eastern Nepal information calculated clearance collected conducted confidence coronavirus Course COVID-19 cross-sectional ethical review board Frequency Health help information interval knowledge media Nepal Participants Point Population preventive measure preventive measures professionals proportion questionnaire Rapid selected service Spread spread of COVID-19 Statistical Package Strong the disease was done was used website WHO [DOI] 10.31729/jnma.5096 PMC 바로가기 [Article Type] Original Article
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020회복된 COVID-19 사례에서 SARS-CoV-2 RNA 방출 및 회복된 COVID-19 사례 및 밀접 접촉에서 SARS-CoV-2에 대한 항체 존재, 태국, 2020년 4월-6월Research Article Published on 2020-10-292022-08-13 Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody Antibody Response Antibody responses antivirals approved blood sample Blood samples caused clearance close contact combating Contact coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 case COVID-19 cases Defense detectable disease onset Disease surveillance effective emerging disease evaluated examined Hospitalized Host host defenses IgA antibodies IgA antibody IgG IgG antibodies IgM infected individual infected individuals information levels of antibody natural history Patient pattern positive presence of antibody provide recovered COVID-19 patient Recovered COVID-19 patients recovered patient recovered patients remained respiratory SARS-CoV-2 SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus spread of COVID-19 tested Vaccine Viral viral clearance Viral RNA Viral RNA shedding [DOI] 10.1371/journal.pone.0236905 PMC 바로가기 [Article Type] Research Article
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial입원한 COVID-19 환자의 결과 개선에 대한 파모티딘의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-132022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] Alanine Alanine transaminase alcoholism All participant All participants allergies allergy allocation approved ARMS aspartate Aspartate transaminase assigned assumption Bandar Abba Bandar Abbas baseline Blinding block randomization blood count Care Chronic kidney disease clearance clinical clinical trial clinical trials code Committee company comparator Comparator group complete blood count concealed control group control groups COVID-19 COVID-19 patient COVID-19 patients creatinine creatinine clearance criteria Dasatinib dialysis discharge dissemination dosage drug therapy electrocardiogram element eligibility criteria End-stage renal disease ethics committee Evidence evidence of excluded expected Famotidine G6PD Glucose Glucose 6 phosphate grouping groups Hepatitis hepatitis C Hospitalized Immunocompromised Immunocompromised patients Infection Intervention Kidney disease Lactate lactate dehydrogenase lead limit Liver disease Local lung infiltration maximum Medical Science Medical Sciences moderate need for dialysis Neratinib normal limit number objective online tool oral contraceptives outcome outcome assessor outcome assessors oxygen oxygen saturation Ozanimod participant Patient patients patients with COVID-19 Pazopanib PCR test pharmaceutical Pharmaceutical Company phosphate Placebo placebo-controlled porphyria positive Pregnancy protocol psoriasis random randomisation randomised randomised controlled trial randomized clinical trial Randomly randomly divided receive recruitment Registered registry renal renal disease renal failure reported Research question researcher respiration rate responsible Rilpivirine Sample size sample size calculation sequence sequence information single-blind Siponimod Standard study drug Study protocol subject submitted technology temperature the ethics committee therapy title Tizanidine transaminase Treatment treatment group Treatment protocol treatment protocols Trial registration two group two groups university Version website were measured written consent [DOI] 10.1186/s13063-020-04773-6 PMC 바로가기 [Article Type] Letter
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice Research Published on 2020-10-122022-10-05 Journal: Acta pharmacologica Sinica [Category] SARS, 치료제, [키워드] Activation administration Blood Blood level characterized clearance Concentration distribution evaluated exhibited intravenous intrinsic kidney liver lung metabolite metabolites mice monophosphate nucleotide pharmacokinetics plasma concentration Protein quantified RDV Remdesivir Respiratory Coronavirus small intestine stability target tissues tissue [DOI] 10.1038/s41401-020-00537-9 [Article Type] Research
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-10-062022-10-29 Journal: Trials [Category] COVID-19, MERS, SARS, [키워드] 1:1 active cancer addition administration age ambient analysed anti-SARS-CoV-2 Antibody titer antibody titres anticipated ARMS assessment baseline Blinding Block randomisation breathing ambient air case report form changes in Chemotherapy clearance clinical clinical condition Clinical outcome collected Confirmed Contact convalescence convalescent plasma COVID-19 criteria cross cytokine profile D-dimer death defined described diagnostic discharge discharged patient dissemination Donor Duration early application eCRF Effect element eligibility eligible eligible patient Enrollment EudraCT exclusion criteria expected experimental arm exploratory feature Follow-up follow-up period group Hematological malignancy high risk high-risk patient high-risk patients with severe disease hospital Hospital admission Hospital stay Hospitalized Immunosuppression inclusion criteria Infection infusion investigator laboratory data Last less mechanical ventilation multicenter non-parametric test number objective Open-label outcome overall survival participant Patient performed plasma positive protocol quarter Radiotherapy randomisation randomised randomised controlled trial randomization system Randomized receive recruitment Registered report reported required Requirement risk routine care Sample size SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 disease SARS-COV-2 infection SARS-CoV-2 viral schedule secondary Secondary objective Seven seven-point ordinal scale Standard Standard of care status Stratification Study protocol subject survival survival rate survival rates Swab table the patient therapy time Total treated Treatment Trial underlying disease Viral load website worsening [DOI] 10.1186/s13063-020-04735-y PMC 바로가기 [Article Type] Letter
Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19COVID-19 환자에서 SARS-CoV-2 RNA의 제거 및 지속성Article Published on 2020-10-012022-09-12 Journal: Journal of medical virology [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome clearance clearance. coronavirus correlated COVID-19 discharge discharged discharged home evaluate evaluated Evidence evidenced immune response Inpatient Isolation mild illness moderate Nasopharyngeal swab organized oropharyngeal swab Patient patients patients with COVID-19 persistence positive resolution of symptoms Result RT-PCR RT-PCR test SARS-CoV-2 SARS-CoV-2 RNA severe disease specimen tested two group two subgroups understanding undetectable upper respiratory tract viral clearance Viral RNA viral RNA clearance weaker immune response [DOI] 10.1002/jmv.26103 PMC 바로가기 [Article Type] Article
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)Original Article Published on 2020-09-262022-10-31 Journal: Clinical & Translational Immunology [Category] COVID-19, [키워드] acute respiratory syndrome Asymptomatic asymptomatic patient Blood clearance clinical feature Cohort collected Comorbidity coronavirus COVID‐19 early diagnosis epidemiological exhibited female highlighting hospital Hospital admission hospitalisation hospitalised IgG IgM IgM seroconversion immune response immune responses Immunoglobulin Laboratory less median time MOST neutralisation objective Patient performed plasma qualitative detection red blood cell response Result SARS‐CoV‐2 SARS‐CoV‐2 Seroconversion seroconversion rate significantly lower significantly shorter symptomatic patient Symptomatic patients the median titre Treatment virus clearance Wuhan [DOI] 10.1002/cti2.1182 PMC 바로가기 [Article Type] Original Article
Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study중환자실 COVID-19 환자의 시간 경과에 따른 지단백질 농도: ApoCOVID 연구 결과Research Article Published on 2020-09-242022-08-13 Journal: PLoS ONE [Category] Biochemistry, COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Admission Anti-inflammatory antioxidant association Bacterial Bacterial sepsis bacterial superinfection caused change cholesterol clearance Concentration conducted consecutive patient coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pneumonia dead patient decrease Diagnosis functions global pandemic HDL HDL-C HDLs High-density lipoprotein High-density lipoproteins Hospitalization Hospitalized ICU ICU admission ICU patient incidence increase in intensive care LDL cholesterol LDL-C lipopolysaccharides lipoprotein Lipoproteins Low-density lipoprotein low-density lipoproteins Mortality neutralize nonsurvivors outcome outcomes Particle Particles Patient pleiotropic Pneumonia profile Prospective Study reference values reported respiratory Result Sepsis Severe COVID-19 pneumonia statistically significant superinfection survival survivor Transport university hospital VAP Ventilator-associated pneumonia were assessed [DOI] 10.1371/journal.pone.0239573 PMC 바로가기 [Article Type] Research Article
Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19Clinical Study Published on 2020-09-232022-10-27 Journal: BioMed Research International [Category] COVID-19, [키워드] Admission blood lymphocyte CD3+ CD4+ CD4+ T cell CD8+ CD8+ T cell China clearance Clinical outcome conducted COVID-19 COVID-19 case cross-sectional cumulative disease Effect effect size evaluate Final glucocorticoid Glucocorticoids group healthy individuals low-dose lymphocyte Lymphocyte count Methylprednisolone Mild mild COVID-19 patients Negative conversion rate no significant difference nucleic acid objective patients peripheral Peripheral blood peripheral lymphocyte Pharyngeal swab positive Result retrospective returned significantly single-center study statistically significant T cell T cell subset T cells the disease the healthy the patient treatment group treatment groups two groups viral nucleic acid were recorded were used without affecting [DOI] 10.1155/2020/2854186 PMC 바로가기 [Article Type] Clinical Study